1. Home
  2. JTAI vs ADXN Comparison

JTAI vs ADXN Comparison

Compare JTAI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JTAI

Jet.AI Inc.

N/A

Current Price

$2.13

Market Cap

8.1M

Sector

Finance

ML Signal

N/A

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$5.89

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JTAI
ADXN
Founded
2018
2002
Country
United States
Switzerland
Employees
9
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
8.6M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
JTAI
ADXN
Price
$2.13
$5.89
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$80.00
N/A
AVG Volume (30 Days)
826.3K
1.9K
Earning Date
05-15-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$86.57
Revenue Next Year
$0.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$5.41
52 Week High
$10.41
$12.05

Technical Indicators

Market Signals
Indicator
JTAI
ADXN
Relative Strength Index (RSI) 24.17 47.00
Support Level $1.46 $5.53
Resistance Level $2.19 $7.37
Average True Range (ATR) 0.67 0.20
MACD -0.29 0.01
Stochastic Oscillator 2.58 33.53

Price Performance

Historical Comparison
JTAI
ADXN

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of fractional and whole interests in aircraft, the sale of jet cards, which enable holders to use certain of the company's and other's aircraft at agreed-upon rates, the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third-party carriers as well as via the company's leased and managed aircraft, direct chartering of its HondaJet Elite aircraft by Cirrus Aviation Services, aircraft brokerage and monthly management and hourly operation of customer aircraft. It also offers the SaaS software to aircraft owners and operators generally: Reroute AI; and DynoFlight. The company operates in a single operating and reportable segment which is private aviation services.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: